Log inSign up
AAOIFI No. 21 screening

Is ETRA halal?

Electra Therapeutics, Inc.

Doubtful

No clear verdict is possible for Electra Therapeutics, Inc. — data is insufficient or the case is contested in fiqh. As a precaution it is NOT included in the halal list.

Checked: 15 October 2026

Exchange

NASDAQ

Price

8.75

Day

+0.00%

Market cap

$553.0M

Industry

Biotechnology

Sector

Healthcare

What the company does

Electra Therapeutics is a late-clinical-stage biotech developing drugs for immune diseases and cancer. Its lead drug ELA026 is an antibody for secondary HLH, a life-threatening hyperinflammatory disorder, with FDA Breakthrough Therapy designation. No commercial revenue; funded by investors (September 2026 IPO).

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $1.98M ÷ current market cap $552.98M = 0.4%

    0.4%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $97.72M ÷ current market cap $552.98M = 17.7%

    17.7%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    —

    No data

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict.

For information (AAOIFI 3/1 note): cash + receivables are 92.0% of total assets (2026-06-30). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.